Inventor · disambiguated record
Michael Badman
Also filed as: BADMAN MICHAEL
4 granted patents·10 pending applications·3 citations·filing 2015–2022
62Inventor score
Files withNOVARTIS AG14
Top patents by PatentIndex Score
14 records- 0173US11344540B2Methods for treating liver disorders using FXR agonistsNOVARTIS AG·Filed 2017·Granted May 31, 2022·1 cites·25 claims
- 0273US11110083B2Methods for treating liver disorders using FXR agonistsNOVARTIS AG·Filed 2017·Granted Sep 7, 2021·1 cites·17 claims
- 0364US11229634B2Methods for treating gastrointestinal disorders using FXR agonistsNOVARTIS AG·Filed 2017·Granted Jan 25, 2022·1 cites·16 claims
- 0461US2022313677A1Methods for treating liver disorders using fxr agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0558US11052069B2Regimes of FXR agonistsNOVARTIS AG·Filed 2017·Granted Jul 6, 2021·0 cites·6 claims
- 0658US2021386729A1Methods for treating liver disorders using fxr agonistsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0758US2021283105A1Novel regimes of fxr agonistsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0853US2021361638A1Fxr agonists for the treatment of liver diseasesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0952US2020276178A1Combinations comprising fxr agonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1052US2019076500A1Combinations comprising fxr agonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1146US2019083473A1Azabicyclooctane derivatives as fxr agonists for use in the treatment of liver and gastrointestinal diseasesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1245US2022347190A1Treatment comprising fxr agonistsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1344US2019161483A1Methods for using fxr agonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1436US2017368038A1Azabicyclooctane derivatives as fxr agonists for use in the treatment of liver and gastrointestinal diseasesNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Badman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →